A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113)

1. Ray-Coquard, I.
2. Hatcher, H.
3. Bompas, E.
4. Casado, A.
5. Westermann, A.
6. Isambert, N.
7. Casali, P.G.
8. Pratap, S.
9. Stark, D.
10. Valverde, C.
11. Anand, A.
12. Huizing, M.
13. Floquet, A.
14. Lindner, L.
15. Hermes, B.
16. Seddon, B.
17. Coens, C.
18. Jones, R.
19. Reed, N.